CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 220 enrolled
Drug / intervention
Multispectral Optoacustic Tomography (MSOT)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04641091
NCT04641091N/ACompleted

Cross-sectional Study of Muscle Perfusion in Patients With PAD by Non-invasive Multispectral Optoacoustic Tomography

University Hospital Erlangen·observational·Posted Nov 23, 2020·Updated Mar 7, 2022

In Brief

An observational study evaluating Multispectral Optoacustic Tomography (MSOT) for Peripheral Vascular Disease and Peripheral Arterial Disease. Completed, enrolled 220 participants across 1 site.

Detailed Summary

The aim of the proposed study is to define an independent parameter for the diagnostic assessment of the perfusion situation of the calf muscle based on Multispectral Optoacoustic Tomography (MSOT) in a cross-sectional collective of healthy volunteers and patients with PAD. The gold standard is a previously performed angiography of the pelvic and femoral vessels based on routine diagnostics, this Imaging is not mandatory for healthy Control group (study group 1). An independent validation group (study group 2) will validate the results found in study group 1.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 23, 2020
Enrollment StartNov 13, 2020
Primary CompletionOct 1, 2021
Study CompletionFeb 18, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.6 years ago

Interventions

Multispectral Optoacustic Tomography (MSOT)device

non-invasive transcutaneous imaging of subcellular muscle components